Kemira Oyj; Filing of Food Additive Petition (Animal Use); Partially Ammoniated Formic Acid; Correction, 14472 [E8-5453]
Download as PDF
14472
Federal Register / Vol. 73, No. 53 / Tuesday, March 18, 2008 / Notices
approval according to the prescribed
content and format.
• 21 CFR 208.24(e)—Each authorized
dispenser of a prescription drug product
for which a Medication Guide is
required, when dispensing the product
to a patient or to a patient’s agent, must
provide a Medication Guide directly to
each patient unless an exemption
applies under § 208.26 (21 CFR 208.26).
• Section 208.26(a)—Requests may be
submitted for exemption or deferral
from particular Medication Guide
content or format requirements.
• 21 CFR 314.70(b)(3)(ii) and 21 CFR
601.12(f)—Application holders must
submit changes to Medication Guides to
FDA for prior approval as supplements
to their applications.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
No. of
Respondents
21 CFR Section
208.20
Annual Frequency
per Response
Total Annual
Responses
Hours Per
Response
Total Hours
10
1
10
320
3,200
208.24(e)
59,000
5,000
295 million
.0014
413,000
208.26(a)
1
1
1
4
4
314.70(b)(3)(ii) and 601.12(f)
5
1
5
72
360
Total
416,564
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA through FDMS only.
Dated: March 11, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–5384 Filed 3–17–08; 8:45 am]
In FR Doc.
E8–316, published on January 11, 2008
(73 FR 2055), the following correction is
made:
On page 2055, in the second column,
in the SUMMARY and SUPPLEMENTARY
INFORMATION sections, ‘‘Oyi’’ is corrected
to read ‘‘Oyj’’.
SUPPLEMENTARY INFORMATION:
Dated: March 7, 2008.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E8–5453 Filed 3–17–08; 8:45 am]
BILLING CODE 4160–01–S
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Food and Drug Administration
[Docket No. 2007F–0478]
Kemira Oyj; Filing of Food Additive
Petition (Animal Use); Partially
Ammoniated Formic Acid; Correction
AGENCY:
Food and Drug Administration,
mstockstill on PROD1PC66 with NOTICES
Health Resources and Services
Administration, HHS.
AGENCY:
Notice of Meeting of the
Advisory Committee on Organ
Transplantation.
ACTION:
HHS.
ACTION:
Meeting of the Advisory Committee on
Organ Transplantation
Notice; correction.
SUMMARY: The Food and Drug
Administration (FDA) is correcting a
document announcing the filing of a
food additive petition that appeared in
the Federal Register of January 11,
2008. FDA is correcting the name of the
petitioner which was misspelled during
document drafting.
DATES: This correction is effective
March 18, 2008.
FOR FURTHER INFORMATION CONTACT:
George K. Haibel, Center for Veterinary
Medicine (HFV–6), Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–267–9019, email: george.haibel@fda.hhs.gov.
VerDate Aug<31>2005
17:39 Mar 17, 2008
Jkt 214001
SUMMARY: Pursuant to Public Law 92–
463, the Federal Advisory Committee
Act, as amended (5 U.S.C. Appendix 2),
notice is hereby given of the fourteenth
meeting of the Advisory Committee on
Organ Transplantation (ACOT),
Department of Health and Human
Services (HHS). The meeting will be
held from approximately 9 a.m. to 5:30
p.m. on May 5, 2008, and from 9 a.m.
to 3 p.m. on May 6, 2008, at the Hilton
Washington D.C./Rockville Executive
Meeting Center, 1750 Rockville Pike,
Rockville, MD 20852. The meeting will
be open to the public; however, seating
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
is limited and pre-registration is
encouraged (see below).
SUPPLEMENTARY INFORMATION: Under the
authority of 42 U.S.C. Section 217a,
Section 222 of the Public Health Service
Act, as amended, and 42 CFR 121.12
(2000), ACOT was established to assist
the Secretary in enhancing organ
donation, ensuring that the system of
organ transplantation is grounded in the
best available medical science, and
assuring the public that the system is as
effective and equitable as possible, and,
thereby, increasing public confidence in
the integrity and effectiveness of the
transplantation system. ACOT is
composed of up to 25 members,
including the Chair. Members are
serving as Special Government
Employees and have diverse
backgrounds in fields such as organ
donation, health care public policy,
transplantation medicine and surgery,
critical care medicine and other medical
specialties involved in the identification
and referral of donors, non-physician
transplant professions, nursing,
epidemiology, immunology, law and
bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.
ACOT will hear presentations on the
‘‘Kidney Disease Outcome Quality
Initiative/Early Kidney Transplantation
Conference’’ held on March 19–20,
2007; adolescent/medication
nonadherence/transitioning from
pediatric-adolescent care to adult care;
revised informed consent
recommendation; recovery/allocation/
transplantation practices outside the
United States; and a final report on the
economics of transplantation. The four
ACOT work groups also will update the
E:\FR\FM\18MRN1.SGM
18MRN1
Agencies
[Federal Register Volume 73, Number 53 (Tuesday, March 18, 2008)]
[Notices]
[Page 14472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5453]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007F-0478]
Kemira Oyj; Filing of Food Additive Petition (Animal Use);
Partially Ammoniated Formic Acid; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a
document announcing the filing of a food additive petition that
appeared in the Federal Register of January 11, 2008. FDA is correcting
the name of the petitioner which was misspelled during document
drafting.
DATES: This correction is effective March 18, 2008.
FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for
Veterinary Medicine (HFV-6), Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-267-9019, e-mail:
george.haibel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In FR Doc. E8-316, published on January 11,
2008 (73 FR 2055), the following correction is made:
On page 2055, in the second column, in the SUMMARY and
SUPPLEMENTARY INFORMATION sections, ``Oyi'' is corrected to read
``Oyj''.
Dated: March 7, 2008.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. E8-5453 Filed 3-17-08; 8:45 am]
BILLING CODE 4160-01-S